We recently compiled a list of the 10 Best Investments During A Recession. The Cigna Group stands sixth on our list among the best investments. TheFly reported on January 9 that Mizuho analyst Ann Hynes maintained a Buy rating on CI and adjusted the price target to $325 from $307. The firm noted that its physician survey shows healthcare utilization growth is slowing sequentially, suggesting the trend may be peaking. Separately, on January 13, 2026, The Cigna Group officially announced that it will relea ...

Core Insights - The Cigna Group is valued at a market cap of $80.6 billion and offers a range of health services and insurance solutions, with Q3 earnings announcement scheduled for October 30, 2025 [1] Financial Performance - Analysts expect Cigna to report a profit of $7.70 per share for Q3 2025, reflecting a 2.5% increase from $7.51 per share in the same quarter last year [2] - For the current fiscal year ending in December, Cigna is projected to report a profit of $29.69 per share, an 8.6% increase from $27.33 per share in fiscal 2024, with further growth expected to $32.97 in fiscal 2026 [3] Stock Performance - Cigna's stock has declined 13.4% over the past 52 weeks, underperforming the S&P 500 Index and the Health Care Select Sector SPDR Fund [4] - Despite reporting better-than-expected Q2 results with adjusted revenue of $67.1 billion and adjusted income of $7.20 per share, the stock fell 10.2% post-announcement due to concerns over a 2.1% decline in total customer relationships [5] Analyst Ratings - Wall Street analysts maintain a "Strong Buy" rating for Cigna, with 17 out of 24 analysts recommending "Strong Buy," and a mean price target of $369.90, indicating a potential upside of 22.4% from current levels [6]